When the Dispute Turns on Clinical Complexity, Bring a Physician
Under the No Surprises Act, most Federal IDR disputes are decided in the provider's favor. Clinical Shield, Netmark's physician-backed review service, strengthens a health plan's position with signed clinical evidence for the disputes where complexity is the argument, so the plan's position rests on a physician's opinion and not only on payment policy and a statistical response based on the QPA.
The IDR math is hard on plans.
IDR volume has outgrown most plans' ability to respond to it. Providers initiated about 2.56 million disputes in 2025. They won roughly 85 to 88 percent of those that reached a decision, and the offers they submitted ran 5 to 10 times the plan's qualifying payment amount (QPA).
Those three numbers explain why cost containment in IDR cannot rely on volume handling alone. A plan that processes every dispute efficiently but arrives with thin documentation in negotiation and arbitration still loses most of them, at a price set by the provider's offer.
Complexity is where the argument is won or lost.
In high-dollar inpatient and complex DRG disputes, the provider's case is clinical. The claim is that the patient was sicker, the procedure harder or the stay more resource-intensive than the plan's payment reflects. A reviewer reading the provider's dispute evidence sees a descriptive, patient-centric clinical narrative.
Most plan responses are generated by operations teams and rely on statistics: the QPA, the fee schedule, the contract terms. They address the price but not the clinical claim. When the plan's evidence is an offer amount tied to the QPA with no clinical rebuttal, the provider's clinical narrative is the only one in front of the arbitrator.
Clinical Shield closes that gap. It puts a credentialed clinical reviewer on the dispute, and on the cases that matter most, a board-certified physician in the same specialty as the billing provider.
Three tiers matched to the dispute.
Not every dispute needs a physician's opinion, and Clinical Shield does not apply one to every case. Review depth scales with what is at stake.
| Tier | Review | Reviewer | Best used for |
|---|---|---|---|
| 1. RN Clinical Screen | Complexity score, coding flags and eligibility red flags | RN with a coding credential | Every dispute |
| 2. Clinical Evidence Brief | A written brief rebutting the provider's complexity claim | RN author with board-certified physician sign-off | Mid-value disputes |
| 3. Sub-Specialty Opinion | A signed expert opinion on the clinical question | Same-specialty, board-certified physician | High-dollar or contestable disputes |
The tiers work as a funnel. Tier 1 screens broadly and flags the disputes that warrant more. Tiers 2 and 3 spend physician time only where the documentation can change the outcome.
Built into the negotiation, not bolted on after it.
Clinical Shield delivers its findings while the dispute is still in negotiation, when a documented clinical position can still move the offer. It connects to the plan's IDR platform through an API or file exchange and handles single cases or batches. It works with IDRIQ, Netmark's IDR cost containment platform, and with the process a plan already runs.
Each opinion is written to hold up in formal arbitration, with the documentation and the named reviewer an arbitrator expects to see.
AI supports the review. Physicians sign it.
Netmark uses AI to route complex DRG cases to the right tier and to summarize medical records so clinical reviewers spend their time on judgment and not on page-turning. Every Tier 2 and Tier 3 opinion is signed by a named, board-certified physician who owns it.
Start with a pilot!
The simplest way to test Clinical Shield is a pilot on a defined set of your current disputes. Netmark reviews the cases at the tier that fits each one, and your team compares the clinical documentation against what it would have submitted on its own.
To scope a pilot, contact Jay Antani, VP, Health Plan Solutions, Netmark Services.